ENERGIZE: A GLOBAL PHASE 3 STUDY OF MITAPIVAT DEMONSTRATING EFFICACY AND SAFETY IN ADULTS WITH ALPHA- OR BETA-NON¿TRANSFUSION-DEPENDENT THALASSEMIA AT Taher; H Al-Samkari; Y Aydinok; M Besser; G Luna; S Gheuens; A Glenthj; AS Goh; A Kattamis; SR Loggetto; KM Musallam; P Ricchi; E Salido-Fiérrez; S Sheth; V Viprakasit; MD Cappellini; KH Kuo;

IMPROVEMENTS IN FATIGUE AND 6-MINUTE WALK TEST IN ADULTS WITH ALPHA- OR BETA-NON¿TRANSFUSION-DEPENDENT THALASSEMIA: THE PHASE 3 ENERGIZE TRIAL OF MITAPIVAT KH Kuo; H Al-Samkari; Y Aydinok; M Besser; S Gheuens; G Luna; A Glenthj; AS Goh; A Kattamis; SR Loggetto; KM Musallam; P Ricchi; E Salido-Fiérrez; S Sheth; V Viprakasit; MD Cappellini; AT Taher;

RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF DEFERIPRONE: SUBGROUP ANALYSIS OF PEDIATRIC PATIENTS IN IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE AND OTHER ANEMIAS M Hamdy; A El-Beshlawy; FS Ebeid; JL Kwiatkowski; J Kanter; B Inusa; S Williams; M Verissimo; D Lee; NT Temin; C Fradette; F Tricta; MS Elalfy;